Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Short Interest Update

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) was the target of a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 1,614,672 shares, a growth of 17.9% from the February 12th total of 1,369,172 shares. Based on an average daily trading volume, of 5 shares, the days-to-cover ratio is presently 322,934.4 days. Based on an average daily trading volume, of 5 shares, the days-to-cover ratio is presently 322,934.4 days.

Shanghai Fosun Pharmaceutical (Group) Trading Up 4.5%

Shares of SFOSF opened at $2.44 on Wednesday. Shanghai Fosun Pharmaceutical has a one year low of $1.62 and a one year high of $3.50. The company’s fifty day moving average price is $2.63 and its 200 day moving average price is $2.99.

Shanghai Fosun Pharmaceutical (Group) Company Profile

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.